| 1. | Chiba, A., S. Oki, K. Miyamoto, H. Hashimoto, T. Yamamura, and S. Miyake: Natural killer T-cell activation by OCH, a sphingosine truncated analogue of α-galactosylceramide, prevents collagen-induced arthritis. Arthr Rheumat 50:305-313, 2004 |
| 2. | Yamamura, T, K. Miyamoto, Zs. Illes, E. Pal, M. Araki, and S. Miyake: NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease. Curr Top Med Chem 4: 561-567, 2004 |
| 3. | Illes, Zs, M. Shimamura, J. Newcombe, N. Oka, and T. Yamamura: Accumulation of Vα7.2Jα33 invariant T cells in autoimmune inflammatory lesions of the nervous system. Int Immunol 16: 223-230, 2004 |
| 4. | Oki, S, A. Chiba, T. Yamamura and S. Miyake: The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J Clin Invest 113: 1631-1640, 2004 |
| 5. | Miyake, S, A. Chiba and T. Yamamura: Potential of targeting natural killer T cells for the treatment of autoimmune diseases. Mod Rheum 14: 279-284, 2004 |
| 6. | Satoh, J-i, T. Yamamura, and K. Arima: The 14-3-3 protein ε isoform, expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis, binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes. Am J Pathol 165: 577-592, 2004 |
| 7. | Rosen, D.B, M. Araki, J.A. Hamerman, T. Chen, T. Yamamura and L.L. Lanier: A structural basis for the association of DAP12 with mouse, but not human, NKG2D. J Immunol 173: 2470-2478, 2004 |
| 8. | Takahashi, K, T. Aranami, M. Endoh, S. Miyake, and T. Yamamura: The regulatory role of natural killer cells in multiple sclerosis. Brain 127: 1917-1927, 2004 |
| 9. | Bedoui, S, S. Miyake, R. Straub, von H?rsten, and T. Yamamura: More sympathy for autoimmunity with neuropeptide Y (NPY)? Trends Immunol 25:508-512, 2004 |
| 10. | Nakai, Y, K. Iwabuchi, S. Fujii, N. Ishimori, N. Dashtsoodol, K. Watano, T. Mishima, C. Iwabuchi, S. Tanaka, J.S. Bezbradica, T. Nakayama, M. Taniguchi, S. Miyake, T. Yamamura, A. Kitabatake, S. Joyce, L. Van Kaer, and K. Onoe: Natural killer T cells accelerate atherogenesis in mice. Blood 104: 2051-2059, 2004 |
| 11. | Mizuno, M, M. Masumura, C. Tomi, A. Chiba, S. Oki, T. Yamamura and S. Miyake: Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice. J Autoimmun 23:293-300, 2004 |
| 12. | Satoh, J-i, and T. Yamamura: Gene expression profile following stable expression of the cellular prion protein. Cell Mol Neurobiol 24:793-814, 2004 |
| 13. | Hashimoto, D, S. Asakura, S. Miyake, T. Yamamura, L. Van Kaer, C. Liu, M. Tanimoto, and T. Teshima: Stimulation of host natural killer T cells by synthetic glycolipid regulates acute graft-versus-host disease by inducing Th2 polarization of donor T cells. J Immunol 174: 551-556, 2005 |
| 14. | Ueno, Y, S. Tanaka, M. Sumii, S. Miyake, S. Tazuma, M. Taniguchi, T. Yamamura and K. Chayama: Single dose of OCH improves mucosal T helper type 1/T helper type 2 cytokine balance and prevents experimental colitis in the presence of Vα14 natural killer T cells in mice. Inflamm Bowel Dis 11:35-41, 2005 |
| 15. | Yu, K.O.A., J.S. Im, A. Molano, Y. Dutronc, P.A. Illarionov, C. Forestier, N. Fujiwara, I. Arias, S. Miyake, T. Yamamura, Y-T. Chang, G.S. Besra, and S.A. Porcelli: Modulation of CD1d-restrotced NKT cell responses by using N-acyl variants of α-galactosylceramides. Proc Natl Acad Sci U S A 102: 3383-3388, 2005 |
| 16. | Satoh, J-i, H. Onoue, K. Arima, and T. Yamamura: Nogo-A and Nogo receptor expression in demyelinating lesions of multiple sclerosis. J Neuropathol Exp Neurol 64: 129-138, 2005 |
| 17. | Satoh, J-i, M. Nakanishi, F. Koike, S. Miyake, T. Yamamoto, M. Kawai, S. Kikuchi, K. Nomura, K. Yokoyama, K. Ota, T. Kanda, T. Fukazawa and T. Yamamura: Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis. Neurobiol Dis 18:537-550, 2005 |
| 18. | Murata, K, T. Toba, K. Nakanishi, B. Takahashi, T. Yamamura, S. Miyake, and H. Annoura: Total synthesis of an immunosuppressive glycolipid, (2S, 3S, 4R)-1-O-(α-D-galactosyl)-2-tetracosanoylamino-1,3,4-nonanetriol. J Org Chem 70: 2398-2401, 2005 |
| 19. | Chiba, A, S. Kaieda, S. Oki, T. Yamamura and S. Miyake: The involvement of Vα14 NKT cells in the pathogenesis of murine models of arthritis. Arthr Rheumat 52: 1941-1948, 2005 |
| 20. | Ota, T, K. Takeda, H. Akiba, Y. Hayakawa, K. Ogasawara, Y. Ikarashi, S. Miyake, H. Wakasugi, T. Yamamura, M. Kronenberg, D.H. Raulet, K. Kinoshita, H. Yagita, M.J. Smyth, and K. Okumura: IFN-γ-mediated negative feedback regulation of NKT cell function by CD94/NKG2. Blood 106: 184-192, 2005 |
| 21. | Toba, T, K. Murata, T. Yamamura , S. Miyake and H. Annoura: A concise synthesis of (3S, 4S, 5R)-1-(α-D-galactopyranosyl)-3-tetracosanoylamino-4,5-decanediol, a C-glycoside analog of immunomodulating α-galactosylceramide OCH. Tetrahedron Letters 46: 5043-5047, 2005 |
| 22. | Ronet, C, S. Darche, M. Leite De Moraes, S. Miyake, T. Yamamura, J. A. Louis, L. H. Kasper, and D. Buzoni-Gatel: NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. J Immunol 175: 899-908, 2005 |
| 23. | Croxford, J.L. and T. Yamamura: Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases? J Neuroimmunol 166: 3-18, 2005 |
| 24. | Miyake, S. and T. Yamamura: Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases. Curr Drug Targets-Immune, Endocrine and Metabolic Disorders 5: 315-322, 2005 |
| 25. | Maeda, M, C. Carpenito, R. Russel, J. Dasanjh, L. Veinotte, H. Ohta, T. Yamamura, R. Tan, and F. Takei: Murine CD160, immunoglobulin-like receptor on NK cells and NKT cells, recognizes classical and non-classical MHC class I and regulates NK cell activation. J Immunol 175: 4426-4432, 2005 |
| 26. | Satoh, J-i, H. Onoue, K. Arima, and T. Yamamura: The 14-3-3 protein forms a molecular complex with heat shock protein Hsp60 and cellular protein. J Neuropathol Exp Neurol 64 :858-868., 2005 |
| 27. | Oki, S, C. Tomi, T. Yamamura, and S. Miyake: Preferential Th2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo. Int Immuol 17:1619-1629, 2005 |
| 28. | Nagayama, S, S. Miyake, and T. Yamamura: Suppression of experimental autoimmune encephalomyelitis by transfer of lymphokine-activated natural killer (NK) cells. Neuroimmunology 13: 239-246, 2005 |
| 29. | Satoh, J-i, Y. Nanri, and T. Yamamura: Rapid identification of 14-3-3-binding proteins by protein microarray analysis. J Neurosci Methods 152: 278-288, 2006 |
| 30. | Satoh, J-i, M. Nakanishi, F. Koike, H. Onoue, T. Aranami, T. Yamamoto, M. Kawai, S. Kikuchi, K. Nomura, K. Yokoyama, K. Ota, T. Saito, M. Ohta, S. Miyake, T. Kanda, T. Fukazawa and T. Yamamura: T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients. J Neuroimmunol 174: 108-118, 2006 |
| 31. | Satoh, J-i, Y. Nanri, H. Tabunoki, and T. Yamamura: Microarrray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early interferon-β-responsive genes in peripheral blood lymphocytes: an implication for IFN-β related adverse effects in multiple sclerosis. BMC Neurology 6:18, 2006 |
| 32. | Pyz, E, O. Naidenko, S. Miyake, T. Yamamura, I. Berberich, S. Cardell, M. Kronenberg, and T. Herrmann: The complementarity determining region (CDR) 2 of BV8S2 (Vb8.2) contributes to antigen recognition by rat iNKT TCR. J Immunol 176:7447-55, 2006 |
| 33. | Satoh, J-i, H. Tabunoki, Y. Nanri, K. Arima, and T. Yamamura: Human astrocytes express 14-3-3σ in response to oxidative and DNA-damaging stresses. Neurosci Res 56: 61-72, 2006 |
| 34. | Croxford, J.L, S. Miyake, Y-Y. Huang, M. Shimamura, and T. Yamamura: Invariant Vα19i T cells regulate autoimmune inflammation. Nat Immunol 7: 987 -994, 2006 |
| 35. | Miyamoto, K, S. Miyake, M. Mizuno, N. Oka, S. Kusunoki, and T. Yamamura: Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2 independent pathway. Brain 129(Pt 8):1984-92, 2006 |
| 36. | Aranami, T, S. Miyake and T. Yamamura: Differential expression of CD11c by peripheral blood NK cells reflects temporal activity of multiple sclerosis. J Immunol 177: 5659-5667, 2006 |